Abstract:A nanozyme‐linked immunosorbent surface plasmon resonance biosensor integrating the low‐cost nano cup chip with the Au@Pt nanoflowers is developed, which can be used for an ultrasensitive (fM‐scale), rapid (minute‐level), and portable (pocket‐size) test for biomarker diagnosis. In order to verify the universality of the platform, three cancer biomarkers (alpha‐fetoprotein, carcinoembryonic antigen, carbohydrate antigen 125) are selected for quantitative detection. Most importantly, clinical samples are used to verify the accuracy and stability of the platform. Developing plasmonic biosensors that are low‐cost, portable, and relatively simple to operate remains challenging. Herein, a novel metasurface plasmon‐etch immunosensor is described, namely a nanozyme‐linked immunosorbent surface plasmon resonance biosensor, for the ultrasensitive and specific detection of cancer biomarkers. Gold‐silver composite nano cup array metasurface plasmon resonance chip and artificial nanozyme‐labeled antibody are used in two‐way sandwich analyte detection. Changes in the biosensor's absorption spectrum are measured before and after chip surface etching, which can be applied to immunoassays without requiring separation or amplification. The device achieved a limit of alpha‐fetoprotein (AFP) detection < 21.74 fM, three orders of magnitude lower than that of commercial enzyme‐linked immunosorbent assay kits. Additionally, carcinoembryonic antigen (CEA) and carbohydrate antigen 125 (CA125) are used for quantitative detection to verify the universality of the platform. More importantly, the accuracy of the platform is verified using 60 clinical samples; compared with the hospital results, the three biomarkers achieve high sensitivity (CEA: 95.7%; CA125: 90.9%; AFP: 86.7%) and specificity (CEA: 97.3%; CA125: 93.9%; AFP: 97.8%). Due to its rapidity, ease of use, and high throughput, the platform has the potential for high‐throughput rapid detection to facilitate cancer screening or early diagnostic testing in biosensing.

A Nanoscale Graphene Oxide-Peptide Biosensor for Real-Time Specific Biomarker Detection on the Cell Surface

Employing Label‐free Electrochemical Biosensor Based on 3d‐reduced Graphene Oxide and Polyaniline Nanofibers for Ultrasensitive Detection of Breast Cancer BRCA1 Biomarker

Ultrasensitive detection of cancer cells and glycan expression profiling based on a multivalent recognition and alkaline phosphatase-responsive electrogenerated chemiluminescence biosensor.

In situ growth of porous platinum nanoparticles on graphene oxide for colorimetric detection of cancer cells.

Study of the Interaction Between Graphene Oxide and Surface-confined Biomolecules to Develop New Kind of Biosensors

Visual and High-Throughput Detection of Cancer Cells Using a Graphene Oxide-Based FRET Aptasensing Microfluidic Chip.

Sensitive Electrochemical Aptamer Biosensor for Dynamic Cell Surface N-Glycan Evaluation Featuring Multivalent Recognition and Signal Amplification on A Dendrimer-Graphene Electrode Interface

In-Situ Integration of 3D C-MEMS Microelectrodes with Bipolar Exfoliated Graphene for Label-Free Electrochemical Cancer Biomarkers Aptasensor

Near-infrared surface plasmon resonance sensor with a graphene-gold surface architecture for ultra-sensitive biodetection

A New Strategy Involving The Use Of Peptides And Graphene Oxide For Fluorescence Turn-On Detection Of Proteins

Parallel profiling of cancer cells and proteins using a graphene oxide functionalized ac-EHD SERS immunoassay

“Three-in-one” Nanohybrids As Synergistic Nanoquenchers to Enhance No-Wash Fluorescence Biosensors for Ratiometric Detection of Cancer Biomarkers

A Nonenzymatic Electrochemical Immunosensor For Ultrasensitive Detection Of Tumor Biomarkers Based On Palladium Nanoparticles Conjugated Reduced Graphene Nanosheets

High-Performance BlueP/WS2 Heterostructure-Based GO-Coated Surface Plasmon Resonance Biosensor for Rapid Detection of Cancer Cells

Nanozyme‐Catalyzed Metasurface Plasmon Sensor‐Based Portable Ultrasensitive Optical Quantification Platform for Cancer Biomarker Screening

A Label-Free and High-Efficient GO-based Aptasensor for Cancer Cells Based on Cyclic Enzymatic Signal Amplification

2D carbon network arranged into high-order 3D nanotube arrays on a flexible microelectrode: integration into electrochemical microbiosensor devices for cancer detection

Graphene Oxide-Circular Aptamer Based Colorimetric Protein Detection on Bioactive Paper

Graphene-based 1D defective photonic crystal biosensor for real-time detection of cancer cells

Electrochemical Cytosensor Based on a Gold Nanostar-Decorated Graphene Oxide Platform for Gastric Cancer Cell Detection

Enhanced performance of an electrochemical aptasensor for real-time detection of vascular endothelial growth factor (VEGF) by nanofabrication and ratiometric measurement